BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14761293)

  • 1. [The expression and their significance of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor during the intrahepatic cholangiocarcinoma carcinogenesis].
    Zhuang DY; Liang P; Fan XH; Chen H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):55. PubMed ID: 14761293
    [No Abstract]   [Full Text] [Related]  

  • 2. Over expression of transforming growth factor-alpha and epidermal growth factor receptor in human hepatic cirrhosis tissues.
    Qiao Q; Zhang J; Wang W; Li Q
    Hepatogastroenterology; 2008; 55(81):169-72. PubMed ID: 18507100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of the epidermal growth factor, transforming growth factor alpha, and their receptor in the human mesonephros and metanephros.
    Bernardini N; Bianchi F; Lupetti M; Dolfi A
    Dev Dyn; 1996 Jul; 206(3):231-8. PubMed ID: 8896979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained activation of epidermal growth factor receptor in cholangiocarcinoma: a potent therapeutic target?
    Tsubouchi H
    J Hepatol; 2004 Nov; 41(5):859-61. PubMed ID: 15519661
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholangiocarcinoma presenting as metastases to the cervical spine.
    Kidambi T; Mahajan A; DiBardino D
    Am J Med; 2011 May; 124(5):e1-2. PubMed ID: 21531219
    [No Abstract]   [Full Text] [Related]  

  • 6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
    Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK; Paik YH; Park JY; Park KH; Bang S; Park SW; Chung JB; Park YN; Song SY
    Am J Clin Oncol; 2006 Apr; 29(2):138-42. PubMed ID: 16601431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
    Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
    Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.
    Inoue Y; Miyamoto S; Fukami T; Shirota K; Yotsumoto F; Kawarabayashi T
    Fertil Steril; 2009 Apr; 91(4):1035-41. PubMed ID: 18325497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
    Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
    J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of bile duct cancer in a 26-year-old man after resection of infantile choledochal cyst.
    Ono S; Sakai K; Kimura O; Iwai N
    J Pediatr Surg; 2008 Jun; 43(6):E17-9. PubMed ID: 18558159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters.
    Snodgrass-Belt P; Gilbert JL; Davis FC
    Brain Res; 2005 Mar; 1038(2):171-82. PubMed ID: 15757633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.